Novel Nanodrug Delivery System Shows Promise in Treating Breast Cancer

Strategic Insights -

Researchers in China have developed a new method for preparing albumin nanoparticles, which have shown potential in improving the anti-breast cancer efficacy of a natural compound called baicalin. The study, published in the International Journal of Biological Macromolecules, aimed to create a novel nanodrug delivery system that could overcome the limitations of current preparation methods for albumin-based nanoparticles. The new method involves using a folic acid-polymer conjugate to modify the albumin nanoparticles, making them more effective at delivering baicalin to cancer cells.

Key Takeaways:

  • The new method for preparing albumin nanoparticles is more efficient, using less organic solvent and preparation time, and producing particles with a smaller size and uniform product compared to existing methods.
  • The encapsulation efficiency (EE) and drug loading (DL) of baicalin in the novel nanodrug delivery system were detected by HPLC, with EE and DL values of 73.12% and 50.56%, respectively.
  • The structural composition and physicochemical properties of the nanoparticles were characterized using transmission electron microscopy (TEM), infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), and X-ray diffraction (XRD).
  • The anti-breast cancer efficacy of the novel nanodrug delivery system was evaluated through cellular uptake, cytotoxicity, apoptosis, cell cycle analysis, and in vivo tumor-bearing mouse studies, showing enhanced cellular uptake and anti-breast cancer activity of baicalin.
  • The research concluded that the developed novel nanodrug delivery system has the potential for further optimization and clinical translation.

Statistics:

  • The particle size of the albumin nanoparticles prepared using the new method ranged from 20 to 300 nm.
  • The polydispersity index (PDI) of the novel nanodrug delivery system was 1.01.
  • The encapsulation efficiency (EE) of baicalin in the novel nanodrug delivery system was 73.12%.
  • The drug loading (DL) of baicalin in the novel nanodrug delivery system was 50.56%.

Sources:

  • Preparation and evaluation of Baicalin-loaded albumin nanoparticles for anti-breast cancer activity. International Journal of Biological Macromolecules, 2025;318:144799.